Pavel Raifeld

Chief Executive Officer at INNOVIVA, INC.

Net worth: 6 M $ as of 30/05/2026

42 year

17 connections

Health Technology

Consumer Services

Finance

Profile

Pavel Raifeld is currently Chief Executive Officer & Director at La Jolla Pharmaceutical Co. since 2023, Chief Executive Officer & Director at Innoviva, Inc. since 2025, Chief Executive Officer at Theravance Respiratory Co. LLC, President & Director at Tetraphase Pharmaceuticals, Inc., President & Director at Entasis Therapeutics Holdings, Inc. since 2022, and President & Director at Entasis Therapeutics, Inc. Formerly, Mr. Raifeld was Senior Member-Healthcare Investment Banking at Credit Suisse Securities (USA) LLC.
Education includes an MBA from The Trustees of Columbia University in The City of New York and undergraduate studies at Harvard University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
INNOVIVA, INC. 0.39%	19/05/2026	285,929 ( 0.39% )	6 M $	30/05/2026

Pavel Raifeld active positions

Companies	Position	Start
INNOVIVA, INC.	Chief Executive Officer	19/05/2020
ENTASIS THERAPEUTICS HOLDINGS INC.	President	10/07/2022
LA JOLLA PHARMACEUTICAL COMPANY	Chief Executive Officer	31/03/2023
TETRAPHASE PHARMACEUTICALS, INC.	President	-
Theravance Respiratory Co. LLC Theravance Respiratory Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures inhaled corticosteroid products	Chief Executive Officer	-
Entasis Therapeutics, Inc. Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases	President	-

All active positions of Pavel Raifeld

Former positions of Pavel Raifeld

Companies	Position	End
Credit Suisse Securities (USA) LLC Credit Suisse Securities (USA) LLC Regional BanksFinance Provides investment banking, asset management and securities brokerage services	Corporate Officer/Principal	-

See the detail of Pavel Raifeld's experience

Training of Pavel Raifeld

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pavel Raifeld's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
La Jolla Pharmaceutical Co. La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions	Health Technology
Tetraphase Pharmaceuticals, Inc. Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics	Health Technology
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Innoviva, Inc. Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs	Health Technology
Credit Suisse Securities (USA) LLC Credit Suisse Securities (USA) LLC Regional BanksFinance Provides investment banking, asset management and securities brokerage services	Finance
Entasis Therapeutics, Inc. Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases	Health Technology
Theravance Respiratory Co. LLC Theravance Respiratory Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures inhaled corticosteroid products	Health Technology
Entasis Therapeutics Holdings, Inc. Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products	Commercial Services